Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 35 | 2024 | 1155 | 10.270 |
Why?
|
| Primary Health Care | 18 | 2023 | 343 | 4.760 |
Why?
|
| Diabetes Mellitus | 19 | 2023 | 742 | 4.400 |
Why?
|
| Hypoglycemic Agents | 13 | 2024 | 342 | 3.440 |
Why?
|
| Psychiatry | 4 | 2023 | 81 | 3.240 |
Why?
|
| Blood Glucose | 14 | 2024 | 838 | 3.060 |
Why?
|
| Depression | 9 | 2024 | 492 | 2.740 |
Why?
|
| Diabetes Complications | 11 | 2023 | 172 | 2.420 |
Why?
|
| Physicians | 7 | 2022 | 675 | 2.300 |
Why?
|
| Mass Screening | 7 | 2024 | 624 | 2.250 |
Why?
|
| Patient Portals | 2 | 2024 | 17 | 1.840 |
Why?
|
| Aging | 10 | 2023 | 696 | 1.800 |
Why?
|
| Medicaid | 7 | 2022 | 224 | 1.690 |
Why?
|
| Humans | 96 | 2024 | 87555 | 1.600 |
Why?
|
| Mental Health Services | 2 | 2021 | 54 | 1.380 |
Why?
|
| Hypothyroidism | 4 | 2023 | 234 | 1.310 |
Why?
|
| Cardiovascular Diseases | 5 | 2023 | 686 | 1.250 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 3 | 2023 | 33 | 1.240 |
Why?
|
| Nutrition Surveys | 7 | 2023 | 111 | 1.230 |
Why?
|
| Healthcare Disparities | 4 | 2022 | 387 | 1.210 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2021 | 58 | 1.210 |
Why?
|
| Patient Protection and Affordable Care Act | 2 | 2019 | 66 | 1.170 |
Why?
|
| Documentation | 3 | 2022 | 101 | 1.170 |
Why?
|
| Depressive Disorder, Major | 2 | 2019 | 164 | 1.160 |
Why?
|
| United States | 22 | 2023 | 6769 | 1.140 |
Why?
|
| Physicians, Primary Care | 2 | 2020 | 105 | 1.110 |
Why?
|
| Qualitative Research | 2 | 2024 | 276 | 1.000 |
Why?
|
| Cross-Sectional Studies | 15 | 2023 | 1674 | 0.950 |
Why?
|
| Adult | 26 | 2024 | 26018 | 0.900 |
Why?
|
| Chronic Disease | 4 | 2022 | 942 | 0.890 |
Why?
|
| Anxiety | 2 | 2024 | 300 | 0.870 |
Why?
|
| Insurance | 1 | 2022 | 12 | 0.860 |
Why?
|
| Hormone Replacement Therapy | 2 | 2022 | 78 | 0.850 |
Why?
|
| Population Health | 1 | 2022 | 33 | 0.840 |
Why?
|
| Hyperthyroidism | 1 | 2022 | 75 | 0.830 |
Why?
|
| Outpatients | 1 | 2022 | 98 | 0.820 |
Why?
|
| Systems Integration | 2 | 2021 | 35 | 0.810 |
Why?
|
| Female | 41 | 2024 | 45191 | 0.810 |
Why?
|
| Schools, Medical | 1 | 2023 | 124 | 0.810 |
Why?
|
| Health Services Accessibility | 4 | 2021 | 409 | 0.800 |
Why?
|
| Hospitalization | 3 | 2021 | 858 | 0.800 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2023 | 220 | 0.790 |
Why?
|
| Quality of Life | 7 | 2021 | 1631 | 0.780 |
Why?
|
| Male | 38 | 2024 | 41502 | 0.770 |
Why?
|
| Metformin | 1 | 2022 | 120 | 0.770 |
Why?
|
| Middle Aged | 29 | 2024 | 25343 | 0.770 |
Why?
|
| Aged | 30 | 2024 | 18644 | 0.760 |
Why?
|
| Thyroid Hormones | 2 | 2023 | 324 | 0.760 |
Why?
|
| Quality-Adjusted Life Years | 6 | 2022 | 136 | 0.750 |
Why?
|
| Financing, Organized | 1 | 2020 | 12 | 0.740 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2020 | 24 | 0.730 |
Why?
|
| Breast Density | 1 | 2020 | 31 | 0.720 |
Why?
|
| Glucose Tolerance Test | 1 | 2020 | 227 | 0.710 |
Why?
|
| State Health Plans | 1 | 2019 | 14 | 0.690 |
Why?
|
| Program Evaluation | 1 | 2020 | 295 | 0.680 |
Why?
|
| Hypertension | 3 | 2016 | 718 | 0.670 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 336 | 0.670 |
Why?
|
| Early Medical Intervention | 1 | 2018 | 19 | 0.650 |
Why?
|
| Quality of Health Care | 3 | 2022 | 382 | 0.650 |
Why?
|
| Veterans | 1 | 2019 | 83 | 0.640 |
Why?
|
| Cost-Benefit Analysis | 7 | 2022 | 453 | 0.630 |
Why?
|
| Clinical Decision-Making | 2 | 2019 | 267 | 0.630 |
Why?
|
| Community Health Centers | 2 | 2022 | 113 | 0.620 |
Why?
|
| Delivery of Health Care | 5 | 2023 | 426 | 0.580 |
Why?
|
| Public Health | 2 | 2021 | 134 | 0.570 |
Why?
|
| Quality Improvement | 2 | 2017 | 431 | 0.570 |
Why?
|
| Health Policy | 2 | 2016 | 182 | 0.560 |
Why?
|
| Cost Sharing | 3 | 2023 | 14 | 0.560 |
Why?
|
| Communication | 1 | 2020 | 443 | 0.560 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2016 | 3 | 0.550 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2021 | 559 | 0.540 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 494 | 0.540 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2019 | 333 | 0.540 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 408 | 0.540 |
Why?
|
| Patient Preference | 1 | 2016 | 105 | 0.530 |
Why?
|
| Coronavirus Infections | 1 | 2021 | 301 | 0.530 |
Why?
|
| HIV Infections | 1 | 2024 | 824 | 0.520 |
Why?
|
| Glucose | 3 | 2022 | 626 | 0.510 |
Why?
|
| Attitude to Health | 1 | 2016 | 221 | 0.510 |
Why?
|
| Medication Adherence | 1 | 2016 | 133 | 0.500 |
Why?
|
| Insurance Coverage | 2 | 2019 | 117 | 0.500 |
Why?
|
| Opioid-Related Disorders | 3 | 2022 | 175 | 0.500 |
Why?
|
| Surveys and Questionnaires | 9 | 2024 | 2556 | 0.500 |
Why?
|
| Risk Assessment | 4 | 2021 | 2260 | 0.490 |
Why?
|
| Leadership | 2 | 2017 | 133 | 0.480 |
Why?
|
| Practice Guidelines as Topic | 2 | 2018 | 1021 | 0.470 |
Why?
|
| Obesity | 2 | 2011 | 955 | 0.470 |
Why?
|
| Preventive Health Services | 1 | 2014 | 38 | 0.470 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 3640 | 0.470 |
Why?
|
| Health Care Reform | 2 | 2015 | 86 | 0.460 |
Why?
|
| Coronary Disease | 1 | 2014 | 258 | 0.440 |
Why?
|
| Medicare | 3 | 2023 | 413 | 0.430 |
Why?
|
| Bariatric Surgery | 2 | 2017 | 194 | 0.430 |
Why?
|
| Comorbidity | 5 | 2018 | 933 | 0.410 |
Why?
|
| Sodium | 2 | 2022 | 331 | 0.380 |
Why?
|
| Informed Consent | 2 | 2023 | 272 | 0.380 |
Why?
|
| Ambulatory Care Facilities | 2 | 2022 | 105 | 0.380 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 164 | 0.360 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2024 | 54 | 0.360 |
Why?
|
| Thyroxine | 4 | 2023 | 346 | 0.350 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 222 | 0.350 |
Why?
|
| Markov Chains | 2 | 2020 | 125 | 0.330 |
Why?
|
| Monte Carlo Method | 2 | 2020 | 185 | 0.320 |
Why?
|
| Models, Economic | 2 | 2020 | 60 | 0.320 |
Why?
|
| Life Expectancy | 3 | 2023 | 86 | 0.310 |
Why?
|
| Thyrotropin | 3 | 2023 | 285 | 0.300 |
Why?
|
| Risk Factors | 5 | 2024 | 5373 | 0.300 |
Why?
|
| Prospective Studies | 6 | 2023 | 4232 | 0.290 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 2734 | 0.270 |
Why?
|
| Appointments and Schedules | 2 | 2023 | 53 | 0.270 |
Why?
|
| Attitude of Health Personnel | 3 | 2022 | 639 | 0.270 |
Why?
|
| Chronic Pain | 2 | 2022 | 156 | 0.260 |
Why?
|
| Job Satisfaction | 2 | 2018 | 73 | 0.260 |
Why?
|
| Young Adult | 6 | 2019 | 6117 | 0.260 |
Why?
|
| Costs and Cost Analysis | 3 | 2020 | 154 | 0.250 |
Why?
|
| Triiodothyronine | 2 | 2023 | 340 | 0.250 |
Why?
|
| Health Care Surveys | 2 | 2019 | 280 | 0.250 |
Why?
|
| Internship and Residency | 2 | 2011 | 1028 | 0.240 |
Why?
|
| Disease Progression | 3 | 2018 | 1473 | 0.240 |
Why?
|
| Efficiency | 2 | 2021 | 38 | 0.230 |
Why?
|
| Physician-Patient Relations | 3 | 2016 | 615 | 0.230 |
Why?
|
| Aged, 80 and over | 8 | 2024 | 6613 | 0.230 |
Why?
|
| California | 4 | 2024 | 142 | 0.230 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 88 | 0.220 |
Why?
|
| Parental Leave | 1 | 2023 | 9 | 0.220 |
Why?
|
| Logistic Models | 2 | 2019 | 1198 | 0.220 |
Why?
|
| Insurance, Health | 2 | 2015 | 157 | 0.220 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2022 | 4 | 0.220 |
Why?
|
| Prevalence | 2 | 2019 | 1246 | 0.220 |
Why?
|
| Faculty | 1 | 2023 | 32 | 0.220 |
Why?
|
| Analgesics, Opioid | 3 | 2022 | 432 | 0.220 |
Why?
|
| Academic Medical Centers | 3 | 2023 | 381 | 0.210 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2022 | 45 | 0.210 |
Why?
|
| Organizational Policy | 1 | 2023 | 55 | 0.210 |
Why?
|
| Antipsychotic Agents | 1 | 2023 | 128 | 0.210 |
Why?
|
| Fee-for-Service Plans | 1 | 2022 | 30 | 0.210 |
Why?
|
| Buprenorphine | 1 | 2022 | 38 | 0.210 |
Why?
|
| Waiting Lists | 1 | 2023 | 184 | 0.200 |
Why?
|
| Dementia | 1 | 2023 | 188 | 0.200 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2022 | 105 | 0.200 |
Why?
|
| Health Care Costs | 2 | 2020 | 232 | 0.190 |
Why?
|
| Time-to-Treatment | 1 | 2021 | 104 | 0.180 |
Why?
|
| Pilot Projects | 2 | 2020 | 855 | 0.180 |
Why?
|
| Computers | 1 | 2020 | 112 | 0.180 |
Why?
|
| Opiate Substitution Treatment | 1 | 2020 | 36 | 0.180 |
Why?
|
| Time Factors | 4 | 2021 | 5262 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 836 | 0.180 |
Why?
|
| Pandemics | 2 | 2023 | 747 | 0.180 |
Why?
|
| Fasting | 1 | 2020 | 163 | 0.180 |
Why?
|
| Emotions | 1 | 2023 | 346 | 0.180 |
Why?
|
| Hospitals | 1 | 2022 | 295 | 0.170 |
Why?
|
| Blood Pressure | 2 | 2015 | 884 | 0.170 |
Why?
|
| Interviews as Topic | 2 | 2019 | 331 | 0.170 |
Why?
|
| Length of Stay | 1 | 2022 | 713 | 0.170 |
Why?
|
| Withholding Treatment | 1 | 2019 | 113 | 0.170 |
Why?
|
| Demography | 2 | 2023 | 179 | 0.160 |
Why?
|
| Internal Medicine | 4 | 2021 | 352 | 0.160 |
Why?
|
| Insulin | 2 | 2023 | 1152 | 0.160 |
Why?
|
| Electronic Health Records | 2 | 2021 | 333 | 0.160 |
Why?
|
| Allied Health Personnel | 1 | 2018 | 19 | 0.160 |
Why?
|
| Work Engagement | 1 | 2017 | 6 | 0.160 |
Why?
|
| Health Status Disparities | 2 | 2023 | 174 | 0.160 |
Why?
|
| Retrospective Studies | 5 | 2023 | 8713 | 0.150 |
Why?
|
| Cohort Studies | 3 | 2023 | 2791 | 0.150 |
Why?
|
| Sepsis | 1 | 2021 | 311 | 0.150 |
Why?
|
| Inservice Training | 1 | 2017 | 38 | 0.150 |
Why?
|
| Urban Health Services | 1 | 2017 | 44 | 0.150 |
Why?
|
| Poverty | 1 | 2019 | 180 | 0.150 |
Why?
|
| Patient Participation | 1 | 2019 | 216 | 0.150 |
Why?
|
| Cost Savings | 1 | 2017 | 68 | 0.150 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2019 | 490 | 0.140 |
Why?
|
| Diet Therapy | 1 | 2016 | 20 | 0.140 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 1031 | 0.140 |
Why?
|
| Financing, Personal | 1 | 2016 | 21 | 0.140 |
Why?
|
| Perception | 1 | 2017 | 176 | 0.140 |
Why?
|
| Patient Care Planning | 1 | 2016 | 79 | 0.140 |
Why?
|
| Linear Models | 2 | 2018 | 423 | 0.140 |
Why?
|
| Sexual and Gender Minorities | 1 | 2019 | 198 | 0.140 |
Why?
|
| Safety-net Providers | 1 | 2016 | 37 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 759 | 0.140 |
Why?
|
| Overweight | 1 | 2017 | 117 | 0.140 |
Why?
|
| Drug Monitoring | 1 | 2016 | 117 | 0.140 |
Why?
|
| Medical Overuse | 1 | 2016 | 36 | 0.130 |
Why?
|
| Life Style | 1 | 2016 | 170 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1818 | 0.130 |
Why?
|
| Phenotype | 1 | 2021 | 2415 | 0.130 |
Why?
|
| Data Accuracy | 1 | 2015 | 31 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 456 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2018 | 1535 | 0.120 |
Why?
|
| Federal Government | 1 | 2014 | 29 | 0.120 |
Why?
|
| Medically Uninsured | 1 | 2014 | 58 | 0.120 |
Why?
|
| Health Surveys | 2 | 2013 | 239 | 0.120 |
Why?
|
| Statistics as Topic | 1 | 2015 | 235 | 0.120 |
Why?
|
| Primary Prevention | 2 | 2013 | 78 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 223 | 0.110 |
Why?
|
| Computer Simulation | 1 | 2018 | 1088 | 0.110 |
Why?
|
| Sex Characteristics | 1 | 2015 | 320 | 0.110 |
Why?
|
| Musculoskeletal Pain | 1 | 2012 | 10 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 360 | 0.110 |
Why?
|
| Registries | 2 | 2013 | 733 | 0.110 |
Why?
|
| Body Mass Index | 2 | 2017 | 762 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2014 | 682 | 0.100 |
Why?
|
| Treatment Outcome | 2 | 2022 | 8054 | 0.100 |
Why?
|
| Glomerular Filtration Rate | 1 | 2013 | 276 | 0.100 |
Why?
|
| Adolescent | 3 | 2019 | 9080 | 0.100 |
Why?
|
| Blood Pressure Determination | 1 | 2012 | 59 | 0.100 |
Why?
|
| United Kingdom | 1 | 2012 | 162 | 0.100 |
Why?
|
| Medical Audit | 1 | 2011 | 39 | 0.100 |
Why?
|
| Burnout, Professional | 1 | 2013 | 95 | 0.100 |
Why?
|
| Prognosis | 2 | 2016 | 3708 | 0.100 |
Why?
|
| Health Status | 2 | 2023 | 364 | 0.100 |
Why?
|
| Hypoglycemia | 1 | 2011 | 105 | 0.090 |
Why?
|
| Secondary Prevention | 1 | 2010 | 159 | 0.090 |
Why?
|
| Patient-Centered Care | 1 | 2011 | 203 | 0.090 |
Why?
|
| Disease Management | 1 | 2011 | 321 | 0.090 |
Why?
|
| Counseling | 1 | 2009 | 158 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 2016 | 0.070 |
Why?
|
| Stroke | 1 | 2015 | 961 | 0.070 |
Why?
|
| Chicago | 1 | 2011 | 1394 | 0.070 |
Why?
|
| Patient Education as Topic | 1 | 2009 | 352 | 0.070 |
Why?
|
| Insulin Glargine | 1 | 2023 | 9 | 0.060 |
Why?
|
| Sulfonylurea Compounds | 1 | 2023 | 62 | 0.060 |
Why?
|
| Algorithms | 1 | 2011 | 1849 | 0.060 |
Why?
|
| Thyroid Function Tests | 1 | 2023 | 119 | 0.060 |
Why?
|
| Buprenorphine, Naloxone Drug Combination | 1 | 2022 | 5 | 0.060 |
Why?
|
| Dronabinol | 1 | 2023 | 56 | 0.050 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 150 | 0.050 |
Why?
|
| Methadone | 1 | 2022 | 42 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2022 | 65 | 0.050 |
Why?
|
| Systems Analysis | 1 | 2021 | 17 | 0.050 |
Why?
|
| Naltrexone | 1 | 2022 | 135 | 0.050 |
Why?
|
| Jurisprudence | 1 | 2021 | 25 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 363 | 0.050 |
Why?
|
| Community Networks | 1 | 2021 | 29 | 0.050 |
Why?
|
| Illinois | 1 | 2021 | 464 | 0.040 |
Why?
|
| Social Stigma | 1 | 2019 | 59 | 0.040 |
Why?
|
| Survival Rate | 2 | 2014 | 1870 | 0.040 |
Why?
|
| Economics, Medical | 1 | 2018 | 6 | 0.040 |
Why?
|
| Motivation | 1 | 2021 | 294 | 0.040 |
Why?
|
| Mental Health | 1 | 2019 | 170 | 0.040 |
Why?
|
| Checklist | 1 | 2018 | 57 | 0.040 |
Why?
|
| Australia | 1 | 2017 | 101 | 0.040 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2016 | 14 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2022 | 592 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2017 | 147 | 0.030 |
Why?
|
| Animals | 1 | 2015 | 26951 | 0.030 |
Why?
|
| Weight Loss | 1 | 2017 | 224 | 0.030 |
Why?
|
| Philippines | 1 | 2015 | 22 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2015 | 51 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2015 | 51 | 0.030 |
Why?
|
| Research Design | 1 | 2018 | 592 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 570 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1695 | 0.030 |
Why?
|
| Clinical Audit | 1 | 2013 | 9 | 0.030 |
Why?
|
| New York City | 1 | 2013 | 59 | 0.030 |
Why?
|
| Midwestern United States | 1 | 2013 | 79 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 901 | 0.030 |
Why?
|
| Sickness Impact Profile | 1 | 2012 | 27 | 0.030 |
Why?
|
| Family Practice | 1 | 2013 | 85 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2012 | 171 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 994 | 0.030 |
Why?
|
| Age Distribution | 1 | 2012 | 200 | 0.030 |
Why?
|
| Medical Errors | 1 | 2013 | 115 | 0.030 |
Why?
|
| Brain | 1 | 2021 | 2245 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2013 | 225 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 1569 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1848 | 0.020 |
Why?
|
| Data Collection | 1 | 2009 | 373 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2009 | 323 | 0.020 |
Why?
|